02. March 2017 Direct compressible excipients for ODT formulations: comparison of traditional and innovative solution - Presentation @ ExcipientFest Americas 2017…

07. February 2017 INTRODUCTION: The pharmacokinetics of excipients in neonates differs from that of older children. In a recent pan--European survey, two thirds of neonates received at least one potentially harmful excipient,…

03. January 2017 Abstract Efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor (NNRTI), is part of first-line therapy for the treatment of human immunodeficiency virus type 1 infection (HIV-1/AIDS). This drug…

18. September 2016 Inflammatory bowel disease (IBD) is an idiopathic, relapsing disease involving chronic inflammation of the digestive tract, either in part or entire. IBD primarily includes Crohn’s disease (CD) and…

24. August 2016 Pediatric Medicines Are Not Child’s Play! AAPS Blog Jennifer Walsh Since the introduction of pediatric regulations in the USA (Pediatric Research Equity Act and Best Pharmaceuticals for Children Act) and…

29. March 2016 8th EuPFI annualconference European Paediatric Formulation Initiative (EuPFI) Annual Conference 20th – 22nd September 2016 in Lisbon, Portugal at Hotel Novotel Lisboa. This Conference Series…